2025-09-29 Sale | 2025-10-01 5:22 pm | MoonLake Immunotherapeutics | MLTX | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP Former 10% Owner | 6,499,978 | $7.2105 | $46,868,184 | 1,994,173 (Indirect) | View |
2023-10-05 Purchase | 2023-10-10 4:00 pm | MoonLake Immunotherapeutics | MLTX | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP 10% Owner | 58,839 | $59.9 | $3,524,297 | 8,494,151 (Indirect) | View |
2023-10-02 Purchase | 2023-10-04 5:52 pm | MoonLake Immunotherapeutics | MLTX | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP 10% Owner | 293,212 | $57.3 | $16,800,343 | 8,435,312 (Indirect) | View |
2023-07-20 Sale | 2023-07-24 4:01 pm | GreenLight Biosciences Holdings PBC | GRNA | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Chen Bihua (See below) | 9,188,659 | $0 | $0 | 0 (Indirect) | View |
2022-12-13 Purchase(A) | 2022-12-21 4:33 pm | Erasca Inc. | ERAS | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Director | 307,692 | $6.5 | $1,999,998 | 11,019,912 (Indirect Direct) | View |
2022-12-13 Purchase | 2022-12-20 5:42 pm | Erasca Inc. | ERAS | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Director | 307,692 | $6.5 | $1,999,998 | 11,019,912 (Indirect Direct) | View |
2021-07-20 Purchase | 2021-07-22 4:10 pm | Erasca Inc. | ERAS | Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Asset Management LP Cormorant Private Healthcare Fund II LP Director | 950,000 | $16 | $15,200,000 | 10,672,219 (Indirect Direct) | View |
2021-07-02 Purchase | 2021-07-07 4:45 pm | Aerovate Therapeutics Inc. | AVTE | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Former 10% Owner | 500,000 | $14 | $7,000,000 | 2,030,691 (Indirect) | View |
2021-06-28 Purchase | 2021-06-30 4:08 pm | Monte Rosa Therapeutics Inc. | GLUE | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP Former 10% Owner | 600,000 | $19 | $11,400,000 | 3,202,200 (Indirect) | View |
2021-04-27 Purchase | 2021-04-29 4:02 pm | Rain Therapeutics Inc. | RAIN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP Former 10% Owner | 450,000 | $17 | $7,650,000 | 2,776,657 (Indirect) | View |
2021-03-30 Purchase | 2021-04-01 4:15 pm | Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 750,000 | $20 | $15,000,000 | 5,114,844 (Indirect) | View |